Search details
1.
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis.
Int J Clin Oncol
; 29(2): 213-221, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38103156
2.
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.
Int J Clin Oncol
; 2024 May 20.
Article
in English
| MEDLINE | ID: mdl-38769191
3.
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
Int J Clin Oncol
; 28(8): 1092-1100, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37227547
4.
Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrence.
Int J Urol
; 30(12): 1147-1154, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37650359
5.
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
Prostate
; 82(1): 3-12, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34559410
6.
Chemical Components in Hedera rhombea Leaves and Their Cytotoxicity.
Chem Pharm Bull (Tokyo)
; 70(2): 175-181, 2022.
Article
in English
| MEDLINE | ID: mdl-35110439
7.
Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer.
Strahlenther Onkol
; 197(11): 976-985, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-33909100
8.
Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer.
Int J Clin Oncol
; 25(3): 479-485, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31512007
9.
Does docetaxel prolong survival of patients with non-metastatic castration-resistant prostate cancer?
Prostate
; 78(7): 498-505, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29473179
10.
Earlier use of androgen receptor-axis-targeted drugs may improve overall survival in patients with non-metastatic castration-resistant prostate cancer.
Prostate
; 78(10): 766-772, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29635810
11.
[EXPRESSION OF PLAKIN FAMILY IN UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT].
Nihon Hinyokika Gakkai Zasshi
; 108(2): 87-95, 2017.
Article
in Japanese
| MEDLINE | ID: mdl-29669982
12.
OUTCOMES AFTER SURGICAL TREATMENT OF UPPER TRACT UROTHELIAL CARCINOMA.
Nihon Hinyokika Gakkai Zasshi
; 107(2): 79-86, 2016.
Article
in Japanese
| MEDLINE | ID: mdl-28442674
13.
[CLINICAL CHARACTERISTICS OF T1 HIGH GRADE BLADDER CANCER].
Nihon Hinyokika Gakkai Zasshi
; 106(2): 71-8, 2015 Apr.
Article
in Japanese
| MEDLINE | ID: mdl-26415356
14.
[RISK FACTORS FOR INTRAVESICAL RECURRENCE AFTER SURGICAL MANAGEMENT OF UROTHERIAL CARCINOMA OF THE UPPER URINARY TRACT].
Nihon Hinyokika Gakkai Zasshi
; 106(4): 231-7, 2015 Oct.
Article
in Japanese
| MEDLINE | ID: mdl-26717780
15.
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer.
Clin Genitourin Cancer
; 22(3): 102075, 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38643665
16.
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis.
Clin Genitourin Cancer
; 22(2): 149-156.e1, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38007354
17.
Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study.
Clin Genitourin Cancer
; : 102082, 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38641443
18.
Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective study.
Urol Oncol
; 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38729868
19.
Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials.
Prostate Cancer Prostatic Dis
; 2023 Jul 18.
Article
in English
| MEDLINE | ID: mdl-37464102
20.
Pagetoid spread of urothelial carcinoma controlled without resection.
IJU Case Rep
; 6(1): 65-69, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36605693